How did we get a COVID-19 vaccine in less than 1 year?

The AACR COVID-19 and Cancer Task Force

Research output: Contribution to journalReview articlepeer-review

Abstract

The successful development of COVID-19 vaccines within an unprecedented short time needs to be followed by rapid vaccine uptake, in particular, in high-risk populations such as patients with cancer. It is important for the scientific research community and cancer physicians to convey the knowledge behind the COVID-19 vaccine development and contribute to build the required trust on their use.

Original languageEnglish (US)
Pages (from-to)2136-2138
Number of pages3
JournalClinical Cancer Research
Volume27
Issue number8
DOIs
StatePublished - Apr 2021

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'How did we get a COVID-19 vaccine in less than 1 year?'. Together they form a unique fingerprint.

Cite this